Form 4 for PFE Pfizer
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001225208-24-003340 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-01 | 2024-02-28 | PFE | BOSHOFF CHRISTOFFEL | EVP | A - Grant | $0.00 | +11.5K | 160.2K | +8% | $0 | |
| 2024-03-01 | 2024-02-28 | PFE | BOSHOFF CHRISTOFFEL | EVP | F - Tax | $27.04 | -4,150 | 156.0K | -3% | -$112.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | A | A | 11,510 | $0.00 | 160,157 | D | — | — | (F1) The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon). |
| 2 | Common | Common Stock | 2024-02-28 | F | D | 4,150 | $27.04 | 156,007 | D | — | — | (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon). |